These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25410581)

  • 21. Mathematical analysis for teratogenic sensitivity.
    Luecke RH; Wosilait WD; Young JF
    Teratology; 1997 Jun; 55(6):373-80. PubMed ID: 9294882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A physiologically based pharmacokinetic model for developmental exposure to BDE-47 in rats.
    Emond C; Raymer JH; Studabaker WB; Garner CE; Birnbaum LS
    Toxicol Appl Pharmacol; 2010 Feb; 242(3):290-8. PubMed ID: 19883674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporation of
    Clewell HJ; Campbell JL; Van Landingham C; Franzen A; Yoon M; Dodd DE; Andersen ME; Gentry PR
    Inhal Toxicol; 2019; 31(13-14):468-483. PubMed ID: 31992090
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.
    Fragki S; Piersma AH; Rorije E; Zeilmaker MJ
    Toxicol Appl Pharmacol; 2017 Oct; 332():109-120. PubMed ID: 28760446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment-A case study of troglitazone.
    Yu L; Li H; Zhang C; Zhang Q; Guo J; Li J; Yuan H; Li L; Carmichael P; Peng S
    Environ Toxicol Pharmacol; 2020 Feb; 74():103296. PubMed ID: 31783317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach.
    Malmborg J; Ploeger BA
    J Pharmacol Toxicol Methods; 2013; 67(3):203-13. PubMed ID: 23280406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic and persistent effects of ethanol exposure on development: an in vivo analysis during and after embryonic ethanol exposure in Caenorhabditis elegans.
    Lin CH; Sa S; Chand J; Rankin CH
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E190-8. PubMed ID: 22725623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological "constants" for PBPK models for pregnancy.
    Young JF; Branham WS; Sheehan DM; Baker ME; Wosilait WD; Luecke RH
    J Toxicol Environ Health; 1997 Dec; 52(5):385-401. PubMed ID: 9388532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic modeling of β-chloroprene metabolism: Probabilistic in vitro-in vivo extrapolation of metabolism in the lung, liver and kidneys of mice, rats and humans.
    Yang Y; Himmelstein MW; Clewell HJ
    Toxicol In Vitro; 2012 Sep; 26(6):1047-55. PubMed ID: 22543297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice.
    Ward KW; Blumenthal GM; Welsch F; Pollack GM
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):311-22. PubMed ID: 9266804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of an Accessible Interface for Pharmacokinetic Modeling and
    Hines DE; Bell S; Chang X; Mansouri K; Allen D; Kleinstreuer N
    Front Pharmacol; 2022; 13():864742. PubMed ID: 35496281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving in vitro to in vivo extrapolation by incorporating toxicokinetic measurements: a case study of lindane-induced neurotoxicity.
    Croom EL; Shafer TJ; Evans MV; Mundy WR; Eklund CR; Johnstone AF; Mack CM; Pegram RA
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):9-19. PubMed ID: 25529470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.
    Song G; Moreau M; Efremenko A; Lake BG; Wu H; Bruckner JV; White CA; Osimitz TG; Creek MR; Hinderliter PM; Clewell HJ; Yoon M
    Toxicol Sci; 2019 Jun; 169(2):365-379. PubMed ID: 30768128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
    Quick DJ; Shuler ML
    Biotechnol Prog; 1999; 15(3):540-55. PubMed ID: 10356275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats.
    Kamgang E; Peyret T; Krishnan K
    SAR QSAR Environ Res; 2008; 19(7-8):669-80. PubMed ID: 19061083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral and dermal developmental toxicity studies of phenylethyl alcohol in rats.
    Politano VT; Diener RM; Christian MS; Hoberman AM; Palmer A; Ritacco G; Adams TB; Api AM
    Int J Toxicol; 2013; 32(1):32-8. PubMed ID: 23385159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.
    Yoon M; Campbell JL; Andersen ME; Clewell HJ
    Crit Rev Toxicol; 2012 Sep; 42(8):633-52. PubMed ID: 22667820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.